CD79A and bronchiectasis: For instance, Hodkinson et al., in a study of 626 patients with primary immunodeficiency, observed that 48% of those with combined IgA and IgM deficiency developed bronchiectasis, even though a high proportion of them were already receiving IgG replacement therapy.